Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)

Reference:
Product nameCytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)
Uniprot IDP16410
Uniprot linkhttps://www.uniprot.org/uniprot/P16410
Origin speciesHomo sapiens (Human)
Expression systemProkaryotic expression
SequenceAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSS GNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSD
Molecular weight13.38 kDa
Protein delivered with Tag?N-terminal His Tag
Purity estimated>90% by SDS-PAGE
BufferPBS pH 7.5, 0.02% SKL
Delivery conditionDry Ice
Delivery lead time in business daysEurope: 5-7 working days
USA & Canada: 7-10 working days
Rest of the world: 5-12 working days
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesEscherichia coli (E.coli)
ApplicationsELISA,WB
Fragment TypeAla37-Asp161
Protein AccessionP16410
Spec:Entrez GeneID1493
Spec:NCBI Gene AliasesCD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3
Spec:SwissProtIDQ9UKN9
NCBI ReferenceP16410
Aliases /SynonymsCytotoxic T-lymphocyte-associated antigen 4,CTLA-4,CD152
ReferencePX-P4782
NoteFor research use only

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)”

Your email address will not be published. Required fields are marked *

Related products

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1177 400€
Zalifrelimab  Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Zalifrelimab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1559 400€
Nurulimab  Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1597 400€
Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1647 400€
Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade
Biosimilar

Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade

PX-TA1648 400€
Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade
Biosimilar

Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade

PX-TA1665 400€
Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade
Biosimilar

Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade

PX-TA1765 400€
Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1781 400€
Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade
Biosimilar

Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade

PX-TA1813 400€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products